BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8879803)

  • 1. Resistance to fluconazole and amphotericin B in a patient with AIDS who was being treated for candidal esophagitis.
    Le TP; Tuazon CU; Levine M; Borum M; Rollhauser C
    Clin Infect Dis; 1996 Sep; 23(3):649-50. PubMed ID: 8879803
    [No Abstract]   [Full Text] [Related]  

  • 2. Extensive esophageal candidiasis in the absence of oral lesions in pediatric AIDS.
    Braegger CP; Albisetti M; Nadal D
    J Pediatr Gastroenterol Nutr; 1995 Jul; 21(1):104-6. PubMed ID: 8576800
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
    Tebbe B; Boyvat A; Geilen CC; Wölfer LU; Seibold M; Orfanos CE
    Hautarzt; 1996 Feb; 47(2):136-9. PubMed ID: 8868459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspofungin versus amphotericin B for the treatment of Candidal esophagitis.
    Chocarro Martínez A; Gonzalez A; Garcia I
    Clin Infect Dis; 2002 Jul; 35(1):107; author reply 107-8. PubMed ID: 12060888
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
    Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C
    Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infection.
    Ruhnke M; Adler A; Müller FM
    Clin Microbiol Infect; 2000 Apr; 6(4):220-3. PubMed ID: 11168112
    [No Abstract]   [Full Text] [Related]  

  • 7. Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.
    Vuffray A; Durussel C; Boerlin P; Boerlin-Petzold F; Bille J; Glauser MP; Chave JP
    AIDS; 1994 May; 8(5):708-9. PubMed ID: 8060555
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluconazole resistance in Candida in patients with AIDS--a therapeutic approach.
    Ng TT; Denning DW
    J Infect; 1993 Mar; 26(2):117-25. PubMed ID: 8473758
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
    Nolte FS; Parkinson T; Falconer DJ; Dix S; Williams J; Gilmore C; Geller R; Wingard JR
    Antimicrob Agents Chemother; 1997 Jan; 41(1):196-9. PubMed ID: 8980781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of candidal osteomyelitis with fluconazole following failure with liposomal amphotericin B.
    Turner DL; Johnson SA; Rule SA
    J Infect; 1999 Jan; 38(1):51-3. PubMed ID: 10090510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
    Fichtenbaum CJ; Zackin R; Rajicic N; Powderly WG; Wheat LJ; Zingman BS
    AIDS; 2000 May; 14(7):845-52. PubMed ID: 10839593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.
    Louie A; Banerjee P; Drusano GL; Shayegani M; Miller MH
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2841-7. PubMed ID: 10582869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient therapy of HIV-associated oral and oesophageal candidosis.
    Ustianowski AP; Leake H; Evans S
    Int J STD AIDS; 1997 Sep; 8(9):592-4. PubMed ID: 9292351
    [No Abstract]   [Full Text] [Related]  

  • 15. Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.
    Myoken Y; Kyo T; Kohara T; Fujihara M; Sugata T; Mikami Y
    Clin Infect Dis; 2003 Jun; 36(11):1496-7. PubMed ID: 12766847
    [No Abstract]   [Full Text] [Related]  

  • 16. [Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
    Eichel M; Just-Nübling G; Helm EB; Stille W
    Mycoses; 1996; 39 Suppl 1():102-6. PubMed ID: 8767280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida infection in HIV positive patients 1985-2007.
    Traeder C; Kowoll S; Arastéh K
    Mycoses; 2008 Sep; 51 Suppl 2():58-61. PubMed ID: 18721333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients.
    Kelly SL; Lamb DC; Kelly DE; Loeffler J; Einsele H
    Lancet; 1996 Nov; 348(9040):1523-4. PubMed ID: 8942815
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis.
    Jafari HS; Sáez-Llorens X; Severien C; Parras F; Friedland I; Rinderknecht S; Ehrett S; Olsen KD; Abramowsky C; McCracken GH
    Antimicrob Agents Chemother; 1994 Jan; 38(1):83-9. PubMed ID: 7511361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis.
    Barbaro G; Barbarini G; Calderon W; Grisorio B; Alcini P; Di Lorenzo G
    Gastroenterology; 1996 Nov; 111(5):1169-77. PubMed ID: 8898629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.